How AI and AWS Are Transforming Rare Disease Detection in Children
Two pioneering health systems are partnering with Amazon Web Services (AWS) to revolutionize the way rare diseases are identified in children. By harnessing the power of artificial intelligence and cloud computing, these hospitals are dramatically shortening the diagnostic journey for thousands of young patients and their families.
The Challenge of Diagnosing Rare Diseases in Children
Rare genetic disorders affect millions of children worldwide, yet many go undiagnosed for years — a painful journey families often call the “diagnostic odyssey.” Traditional diagnostic processes are slow, expensive, and frequently inaccessible to underserved communities. Early detection is critical, as timely intervention can significantly improve outcomes and quality of life.
AWS has stepped in as a key enabler, investing in children’s health innovation through targeted research funding and technology partnerships that put cutting-edge AI tools directly into clinical workflows.
Children’s National Hospital: AI-Powered Facial Analysis
Turning Smartphones Into Diagnostic Tools
Washington, D.C.-based Children’s National Hospital received $1 million in AWS research funding to develop a groundbreaking AI technology that analyzes smartphone camera images to detect subtle changes in infants’ facial features.
These minute physical characteristics — nearly imperceptible to the human eye — can serve as early indicators of rare genetic disorders. By training AI models to identify these patterns, clinicians can flag potential diagnoses far earlier than traditional methods allow.
This innovation is particularly significant because it leverages a device nearly every parent already owns: a smartphone. Rather than requiring expensive specialized equipment or visits to rare disease specialists, the AI-powered tool democratizes early screening, making it accessible in clinics, community health settings, and even at home.
Rady Children’s Hospital: Genomics and Large Language Models
Speeding Up Diagnoses With Smarter Technology
San Diego-based Rady Children’s Hospital, a recipient of AWS’ prestigious $10 million Children’s Health Innovation Award, is taking a different but equally powerful approach. The hospital is deploying large language models (LLMs) to accelerate rare disease diagnoses and ensure that genomics testing reaches the children who need it most.
Large language models are able to rapidly process and interpret vast volumes of clinical data, medical literature, and patient records — identifying patterns and potential diagnoses that might otherwise take months or years to surface through conventional means.
Genomics Testing for Those Who Need It Most
One of the most compelling aspects of Rady’s program is its focus on equitable access. By using AI to prioritize patients most likely to benefit from genomic testing, the hospital is ensuring that limited resources are directed toward children with the highest clinical need — regardless of their socioeconomic background or geographic location.
As Matthew Bainbridge, PhD, a supervising research scientist at the Rady Children’s Institute for Genomic Medicine, stated in a February 19 AWS blog post: “Leveraging AI and cloud computing is a critical step as we work towards making genetic testing more equitable, inexpensive, and widely available. Working with AWS allows us to utilize their expertise in AI and cloud computing to improve the speed and access to pediatric genetic testing, ultimately shortening a child’s diagnostic odyssey.”
Making Genetic Testing More Equitable
Both hospital initiatives share a unifying mission: making rare disease detection faster, cheaper, and more accessible for all children — not just those with access to top-tier medical centers. AI-driven tools have the potential to eliminate geographic and financial barriers that have historically left many families without answers for years.
Cloud computing infrastructure provided by AWS ensures that these AI models can scale efficiently, processing large datasets securely and delivering real-time insights to clinicians across diverse care settings.
The Future of Pediatric Rare Disease Diagnosis
The collaborations between AWS, Children’s National Hospital, and Rady Children’s Hospital represent a blueprint for the future of pediatric medicine. As AI technology continues to evolve, its integration into rare disease diagnostics promises shorter diagnostic timelines, improved patient outcomes, and a more equitable healthcare landscape for children everywhere.
With continued investment in health innovation and the responsible deployment of AI, the dream of universal access to early genetic screening is becoming an achievable reality.
